The clinical course suggested that recombinant alpha-2b peginterferon plus ribavirin provoked type 1 diabetes mellitus, therefore, in patients who are candidates for interferon therapy the presence of pancreatic autoantibodies and the fasting plasma glucose level should be investigated before and during treatment.
type 1 diabetes mellitus
ribavirin
type 1 diabetes mellitus
recombinant alpha-2b peginterferon